1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-12-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 14513040 2024-12-01 2025-11-30 14513040 2025-11-30 14513040 2024-11-30 14513040 2023-12-01 2024-11-30 14513040 2024-11-30 14513040 2023-11-30 14513040 bus:Director1 2024-12-01 2025-11-30 14513040 core:WithinOneYear 2025-11-30 14513040 core:WithinOneYear 2024-11-30 14513040 bus:Micro-entities 2024-12-01 2025-11-30 14513040 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 14513040 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 14513040 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 14513040 bus:FullAccounts 2024-12-01 2025-11-30
COMPANY REGISTRATION NUMBER: 14513040
PHYTA BIODESIGN LTD
Filleted Unaudited Financial Statements
30 November 2025
PHYTA BIODESIGN LTD
Statement of Financial Position
30 November 2025
2025
2024
£
£
£
Fixed assets
2,250
-------
----
Current assets
208,486
200
Creditors: amounts falling due within one year
2,025
478
---------
----
Net current assets/(liabilities)
206,461
( 278)
---------
----
Total assets less current liabilities
208,711
( 278)
Accruals and deferred income
120
480
---------
----
208,591
(758)
---------
----
Capital and reserves
208,591
( 758)
---------
----
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: Nil).
2. Director's advances, credits and guarantees
At the balance sheet date, the company had an outstanding loan to the director of £6,001.92 (2024: £Nil). The loan is unsecured, interest-free and repayable on demand.
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 6 August 2026 , and are signed on behalf of the board by:
Mr Z Ansari
Director
Company registration number: 14513040
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 11, Ormond House Medway Street, London, SW1P 2TB, England.